Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Mr. Swartz did not START buying PPHM shares on the open market.

RE: Mr. Swartz did not START buying PPHM shares on the open market.

posted on Sep 16, 2005 02:41PM
Never said he STARTED buying PPHM. Said he was buying shares PPHM on the open market. Correct me if I`m wrong, but as I read the 10Ks for 2004 and 2005 we`ve paid $5 million in interest on the debentures/notes. On top of that we paid $1.8 million to renegociate with our debenture holders. All this is on the backs of the folks who bought the shares up until the last debenture deal. As I`ve said before, it appears there are still debenture commitments in existence. Perhaps we have to renegociate those before anything else happens. But, and let me know if you think I`m wrong, he made his money off of share dilution selling converted shares on the open market and interest on the open market to buyers over the last 4 years. In light of the turnaround in the company, I think that he should START considering purchasing PTSC shares on the open market.

Share
New Message
Please login to post a reply